Adverse Events Associated With Coprescription of Phosphodiesterase Type 5 Inhibitors and Oral Organic Nitrates in Male Patients With Ischemic Heart Disease

Authors: Anders Holt, Paul Blanche, Aksel Karl Georg Jensen, Nina Nouhravesh, Deepthi Rajan, Mads Hashiba Jensen, Mohammed El-Sheikh, Anne-Marie Schjerning, Morten Schou, Gunnar Gislason, Christian Torp-Pedersen, Patricia McGettigan, Morten Lamberts

Published: 2022-04-18

DOI: 10.7326/m21-3445

Source: Full article

---

Abstract

No abstract found.